56 results
Page 3 of 3
8-K
EX-99.1
iaql41h
4 Jan 21
Aravive Announces Board Member Transition to Advisory Role
4:11pm
8-K
EX-99.1
fkx k79uhitddt7xkjn
19 Nov 20
Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
7:10am
8-K
EX-99.2
tp9egvh yt
19 Nov 20
Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
7:10am
8-K
EX-99.1
w9do4swrlzy df2dwli
5 Nov 20
Aravive Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
4:31pm
8-K
EX-99.1
n4hse
8 Oct 20
Regulation FD Disclosure
5:01pm
8-K
EX-99.1
j01seuuecu rl
3 Aug 20
Aravive Reports Second Quarter 2020 Financial Results and Provides Recent Corporate Updates
4:10pm
8-K
EX-99.2
nfyxjz uus
23 Jul 20
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500
7:05am
8-K
EX-99.1
yx0qzs72d5cilxi4u8
23 Jul 20
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500
7:05am
424B3
lvgnk kmhwas
14 Jul 20
Prospectus supplement
4:05pm